Literature DB >> 27095798

Changes in early-career family physicians' antibiotic prescribing for upper respiratory tract infection and acute bronchitis: a multicentre longitudinal study.

Parker J Magin1, Simon Morgan2, Amanda Tapley2, Kim M Henderson2, Elizabeth G Holliday3, Jean Ball3, Joshua S Davis4, Anthea Dallas5, Andrew R Davey6, Neil A Spike7, Lawrie McArthur8, Rebecca Stewart9, Katie J Mulquiney2, Mieke L van Driel5.   

Abstract

BACKGROUND: Inappropriate antibiotic prescription and subsequent antibacterial resistance are major threats to health worldwide.
OBJECTIVES: We aimed to establish whether early-career 'apprenticeship-model' experience in family practice influences antibiotic prescribing for respiratory tract infections and to also establish other associations of antibiotic prescribing changes during this early-career experience.
METHODS: A longitudinal analysis (2010-2014) of a cohort study of Australian GP registrars' (vocational trainees') consultations. Registrars from five regional training programs recorded data from 60 consecutive consultations, once each 6-month training Term, including the diagnoses managed and medications prescribed. The outcomes were whether an antibiotic was prescribed for the diagnoses 'upper respiratory tract infection (URTI)' and 'acute bronchitis/bronchiolitis'. Generalized linear mixed modelling was used to account for repeated measures on registrars and to include the time component: 'Term'.
RESULTS: A total of 856 registrars recorded 108759 consultations, including 8715 'URTI' diagnoses (5.15% of diagnoses) and 2110 'acute bronchitis/bronchiolitis' diagnoses (1.25%). Antibiotics were prescribed in 16.3% [95% confidence interval (CI) 14.9-17.8] of URTI and 72.2% (95% CI 69.6-74.6) of acute bronchitis/bronchiolitis diagnoses. Moving from an earlier to later term did not significantly influence registrars' antibiotic prescribing for URTI [adjusted odds ratio (OR) 0.95; 95% CI 0.87, 1.04, P = 0.27] or acute bronchitis/bronchiolitis [OR 1.01 (95% CI 0.90-1.14), P = 0.86]. Significant associations of antibiotic prescribing for URTIs were the registrar being non-Australian educated, greater patient age, practices not privately billing patients, pathology being ordered, longer consultation duration and the registrar seeking in-consultation information or advice (including from their supervisor).
CONCLUSIONS: Early-career experience/training failed to produce rational antibiotic prescribing for URTI and acute bronchitis/bronchiolitis. Our findings suggest that prescribing interventions could target the registrar-supervisor dyad.
© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Antibacterial agents; family practice; general practice; inappropriate prescribing; physician practice patterns; respiratory tract infections.

Mesh:

Substances:

Year:  2016        PMID: 27095798     DOI: 10.1093/fampra/cmw025

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  3 in total

1.  Changes of Treg and Th17 cells as well as cytokines in children with acute bronchitis.

Authors:  Zhiqiang Tu; Haiyan Xue; Wei Chen; Lanfang Cao; Weiqi Zhang
Journal:  Exp Ther Med       Date:  2017-08-22       Impact factor: 2.447

2.  'Low-value' clinical care in general practice: associations of low value care in GP trainees' practice, including formative and summative examination performance - protocol for cross-sectional and retrospective cohort study analyses using the QUestionable In Training Clinical Activities (QUIT-CA) index.

Authors:  Parker Magin; Anna Ralston; Amanda Tapley; Elizabeth Holliday; Jean Ball; Mieke L van Driel; Andrew Davey; Linda Klein; Kristen FitzGerald; Neil Spike; Alison Fielding
Journal:  BMJ Open       Date:  2022-05-11       Impact factor: 3.006

3.  Interventions to reduce inappropriate prescribing of antibiotics for acute respiratory tract infections: summary and update of a systematic review.

Authors:  Marian S McDonagh; Kim Peterson; Kevin Winthrop; Amy Cantor; Brittany H Lazur; David I Buckley
Journal:  J Int Med Res       Date:  2018-07-01       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.